What is the difference between shockable and non-shockable cardiac arrest, specifically ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT) versus pulseless electrical activity (PEA) or asystole?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Cardiac arrest should be managed based on the initial heart rhythm, with shockable rhythms (ventricular fibrillation and pulseless ventricular tachycardia) requiring immediate defibrillation and non-shockable rhythms (asystole and pulseless electrical activity) requiring high-quality CPR and identification of reversible causes. The most recent and highest quality study, 1, provides the basis for this approach, emphasizing the importance of early rhythm identification and appropriate intervention. Key considerations in managing cardiac arrest include:

  • Delivering a shock (120-200J biphasic or 360J monophasic) for shockable rhythms, followed by immediate CPR for 2 minutes before rhythm reassessment, as recommended by 1.
  • Administering epinephrine 1mg IV/IO every 3-5 minutes for both shockable and non-shockable rhythms, with the suggestion of administering it after initial defibrillation attempts are unsuccessful for shockable rhythms, as stated in 1.
  • Focusing on high-quality CPR without interruption and identifying potential reversible causes (the "H's and T's") for non-shockable rhythms, as emphasized by 1. The distinction between shockable and non-shockable rhythms is crucial, as defibrillation can rapidly convert shockable rhythms to an organized rhythm with perfusion, while non-shockable rhythms require focus on CPR quality and addressing underlying causes, as highlighted by 1. Survival rates are generally higher for shockable rhythms (15-40%) compared to non-shockable rhythms (less than 15%), as noted in the example answer, but the most recent study 1 does not provide specific survival rates, instead focusing on the importance of early and appropriate intervention. In real-life clinical practice, it is essential to prioritize the approach based on the most recent and highest quality evidence, which is 1 in this case, to optimize outcomes in terms of morbidity, mortality, and quality of life.

From the Research

Shockable vs Non-Shockable Cardiac Arrest

  • Shockable cardiac arrest refers to ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT), which can be treated with defibrillation 2, 3, 4, 5, 6.
  • Non-shockable cardiac arrest refers to pulseless electrical activity (PEA) or asystole, which cannot be treated with defibrillation 2, 3, 5.

Factors Associated with Shockable Rhythms

  • Monitored cardiac arrest, witnessed cardiac arrest, and specific cardiac diseases (e.g. ischemic heart disease, dysrhythmias, and valvular heart disease) are associated with initial shockable rhythm 3.
  • Higher age, female sex, and specific non-cardiovascular comorbidities (e.g. overweight and obesity, renal disease, and pulmonary cancer) are associated with an initial non-shockable rhythm 3.

Treatment and Outcomes

  • The use of epinephrine during cardiopulmonary resuscitation (CPR) is recommended to increase coronary blood flow and perfusion pressure, but its beta-stimulation may have deleterious effects 2, 4.
  • Beta-blockade has been studied as a potential treatment for cardiac arrest due to VF/VT, with some evidence suggesting it may reduce myocardial oxygen requirements and improve postresuscitation myocardial function 4.
  • The incidence of VF has been noted to be progressively decreasing in multiple studies of out-of-hospital cardiac arrests (OHCA), likely due to improved medical and surgical therapies for ischemic heart disease and the widespread use of implantable cardiac defibrillators (ICDs) 5.

Related Questions

What are the common causes of cardiac arrest?
What are the defibrillable cardiac rhythms?
What are the steps for defibrillation in a patient with ventricular fibrillation or pulseless ventricular tachycardia?
What are the differences between ventricular tachycardia (VT) without pulse and pulseless electrical activity (PEA), and how to recognize and differentiate them?
What is the ACLS (Advanced Cardiovascular Life Support) algorithm for arrhythmia?
What is the diagnosis for a postpartum woman with hypotension, tachycardia, hypoxia, and profuse vaginal bleeding following a generalized tonic-clonic seizure after an uncomplicated spontaneous vaginal delivery (SVD) at term?
What is the mechanism of action of Tribulus terrestris?
What is the appropriate management for a pregnant woman with type 1 diabetes mellitus, hypertension, impaired renal function, and proteinuria at 10 weeks gestation?
What is the cause of urinary urgency and incontinence in a patient with multiple sclerosis (MS) and a contracted, small bladder?
What is the diagnosis for a 26-year-old pregnant woman (gravida 1, para 0) at 20 weeks gestation with a history of asthma, presenting with intermittent nonproductive cough, chest tightness, and shortness of breath, particularly at night?
What is the diagnosis for a 39-year-old woman experiencing stress urinary incontinence, characterized by involuntary loss of urine during physical activities, coughing, and laughing, with a history of vaginal deliveries and gestational diabetes mellitus (GDM), presenting with normal temperature, normotension, and normal pulse, and a body mass index (BMI) of 24 kg/m2, with a negative urinalysis for nitrites and leukocyte esterase?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.